register

Marketing & Strategy

91% of clinicians use reprints to improve patient care

Health Industry Hub | November 18, 2019 |

For doctors, getting patient care right can be a case of life or death. They need to stay up to date with the latest research in their field, but that takes time – something that’s in short supply. It would seem logical, then, that doctors would welcome relevant and important medical studies in their inboxes, which they could use when diagnosing and treating patients.

With this in mind, pharmaceutical companies often sponsor and distribute reprints – republished versions of medical studies that doctors can use in their work, which are emailed to them for free.

Elsevier recently carried out an APAC based survey of physicians (download below) to find out whether doctors find these reprints useful, and to what extent reprints impact their work with patients. Carried out in December 2018 and January 2019, the survey asked physicians to share their experience using reprints.

The aim of the research was to understand how primary care physicians and specialists access and use scientific articles in reprint format, and why they choose certain content.

The responses provided insights across care areas: 343 physicians from APAC responded; about 80 percent were medical specialists and 20 percent were general practitioners.

Download the medical reprints infographic


News & Trends - Pharmaceuticals

Clinical and Laboratory Haematologist and Lead of the Molecular Haematology Service

Clinicians call for closer monitoring of patients post CAR T therapy

Health Industry Hub | February 17, 2025 |

Australian clinicians are raising questions about whether cancer patients need closer monitoring after receiving CAR T-cell therapy. A Peter MacCallum […]

More


News & Trends - MedTech & Diagnostics

Next-gen surgical mesh to fill critical gap after ban

Next-gen surgical mesh to fill critical gap after regulatory ban

Health Industry Hub | February 17, 2025 |

Next-generation urogynaecological surgical mesh implants are on the horizon for women suffering from pelvic organ prolapse (POP). This development aims […]

More


News & Trends - Pharmaceuticals

Contraceptive lawsuit against Bayer fails

Contraceptive lawsuit against Bayer fails

Health Industry Hub | February 17, 2025 |

The Victorian Supreme Court has dismissed a class action against Bayer for an allegedly defective contraceptive device. Justice Andrew Keogh […]

More


News & Trends - Pharmaceuticals

NSW Government ignored warnings since 2018: Mental health system unravels as psychiatrists quit en masse

NSW Government ignored warnings since 2018: Mental health system unravels as psychiatrists quit en masse

Health Industry Hub | February 17, 2025 |

The New South Wales Labor government’s plan to “redesign” the state’s mental health system, while excluding psychiatrists, has sparked intense […]

More


This content is copyright protected. Please subscribe to gain access.